Profile and Organization
Names | Figures | Facts
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company’s products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and high earning power.
The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2009, Bayer employed 108,400 people and had sales of €31.2 billion. Capital expenditures amounted to €1.7 billion, R&D expenses to €2.7 billion.
Organization
Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Center supports the Group Management Board in its task of strategic leadership.
Organization chart with management structure and fields of activity
Business operations are the responsibility of the subgroups:
- Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products. » more
- Bayer CropScience, with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control.
» more - Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses. » more
- Bayer Business Services is the Bayer Group’s international competence center for it-based services. » more
- Bayer Technology Services is the global technological backbone for the Bayer Group and a major innovation driver. » more
- Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training. » more
Corporate Governance
Dual governance system with the following governance bodies:
| Board of Management: | six members, Chairman: Werner Wenning |
| Supervisory Board: | 20 members, Chairman: Dr. Manfred Schneider |
Products
The Bayer Group markets some 5,000 products. Best-sellers include:
- in the external link: health care field: Yasmin®/YAZ®/Yasminelle®, Betaferon®/Betaseron®, Kogenate®, Adalat®, Avalox®/Avelox®
- in the external link: nutrition field: Confidor®/Gaucho®/Admire®/Merit®, Flint®/Stratego®/Sphere®
- in the field of external link: high-tech materials: Makrolon®, Baydur®, Bayflex® Footwear, Desmodur®/Desmophen®
Locations
Bayer is represented around the world by 302 companies*. Global headquarters are in Leverkusen, Germany.
* fully consolidated subsidiaries (as of Dec. 31, 2009)
Workforce
On December 31, 2009, the Bayer Group had 108.400 employees worldwide (2007: 108.600). North America accounted for 16.300 of these employees, while 21.600 were based in Asia-Pacific, 16.000 in Latin America/Africa/Middle East and 54.500 in Europe. In Germany we had 36.700 employees, who made up 33,9 percent of the Group workforce.
| Image: workforce | 108.400 employees worldwide (as of December 31, 2009), including: 54.500 in Europe 16.300 in North America 21.600 in Asia-Pacific 16.000 in Latin America/Africa/Middle East |
external link: Bayer stock
- included in nearly all the external link: major share indices
- traded on all German external link: stock exchanges
- external link: dividend per share: EUR 1.40
Bayer Group Key Data
| Bayer Group | 2008 |
2009 |
Change |
| Sales | 32,918 |
31,168 |
-5.3 |
| EBITDA1 | 6,266 |
5,815 |
-7.2 |
| EBITDA before special items | 6,931 |
6,472 |
-6.6 |
| EBIT2 | 3,544 |
3,006 |
-15.2 |
| EBIT before special items | 4,342 |
3,772 |
-13.1 |
| Income before income taxes | 2,356 |
1,870 |
-20.6 |
| Net income | 1,719 |
1,359 |
-20.9 |
| Earnings per share (in €)3 | 2.22 |
1.70 |
-23.4 |
| Gross cash flow4 | 5,295 |
4,658 |
-12.0 |
| Net cash flow5 | 3,608 |
5,375 |
+49.0 |
| Capital expenditures as per segment table | 1,982 |
1,669 |
-15.8 |
| Research and development expenses | 2,653 |
2,746 |
+3.5 |
| Dividend per Bayer AG share (€) | 1.40 |
1.40 |
0.0 |
2008 figures restated
1-5 for definition see footnotes to external link: Bayer Group Key Data table
1-5 for definition see footnotes to external link: Bayer Group Key Data table
Sales by segment in percent, 2009 (2008 in parentheses)
| Image: Umsatz-Anteile der Teilkonzerne | Reconciliation 3.7% (4.2%) HealthCare 51.3% (46.8%) Pharmaceuticals 33.6% (30.5%) Consumer Health 17.7% (16.3%) CropScience 20.9% (19.4%) Crop Protection 17.4% (16.2%) Environmental Science/BioScience 3.5% (3.2%) MaterialScience 24.1% (29.6%) |